Clinical Report: Epidemiological and Clinical Characteristics of Colorectal Cancer Patients in Bhutan
Overview
This study provides a comprehensive analysis of colorectal cancer patients in Bhutan, highlighting an increasing incidence and the clinical management challenges faced in a lower-middle-income country. The findings underscore the need for improved cancer care infrastructure and early detection strategies.
Background
Colorectal cancer is a significant global health issue, being the third most common cancer and a leading cause of cancer-related mortality. In Bhutan, the rising incidence of colorectal cancer reflects broader trends observed in Asia, where lifestyle changes and an aging population contribute to increased disease burden. Understanding the epidemiological and clinical characteristics of colorectal cancer in Bhutan is crucial for developing targeted interventions.
Data Highlights
No numerical data available in the provided source material.
Key Findings
Colorectal cancer accounted for 4.9% of incident cancer cases among males in Bhutan from 2019 to 2022.
The age-adjusted incidence rate for colorectal cancer was reported as 5.2 per 100,000 population among males.
Stomach cancer was the most common cancer among males, while cervical cancer was the most common among females.
All colorectal cancer cases are primarily managed at the JDW National Referral Hospital, the only facility with onco-surgery services in Bhutan.
There are currently no oncophysicians or radiation oncologists available in Bhutan, highlighting a gap in cancer care.
Clinical Implications
The findings indicate a pressing need for enhanced cancer care services in Bhutan, including the establishment of specialized oncology teams and improved diagnostic facilities. Early detection strategies, such as screening programs, could significantly impact patient outcomes in this population.
Conclusion
This report emphasizes the urgent need for improved colorectal cancer management and prevention strategies in Bhutan, reflecting broader trends in cancer epidemiology in low- and middle-income countries.
